Syros Pharmaceuticals
Latest round
- Series B
Last raised
- Oct 2014
Total raised
- $64M
Investors
- 8
About Syros Pharmaceuticals
Syros Pharmaceuticals, Inc.Founded in 2012 and headquartered in Cambridge, US, Syros Pharmaceuticals, Inc. focuses on genetic medicines that target the underlying causes of disease.83 mn across 11 deals.Syros Pharmaceuticals is dedicated to developing targeted medicines that address the root causes of serious diseases, particularly in oncology. Their primary offerings include therapeutic candidates that are in various stages of clinical development, aimed at enhancing patient outcomes.97 mn for the same year. The company aims to expand its product pipeline with several new drug candidates expected to enter clinical stages in the next few years. Furthermore, they are targeting expansion into international markets, specifically in Europe and Asia-Pacific, to leverage growing healthcare needs and enhance their global footprint.
Who invested in Syros Pharmaceuticals
8 investors across 3 rounds
See all investors in Syros Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Syros Pharmaceuticals
Who invested in Syros Pharmaceuticals?
Syros Pharmaceuticals has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syros Pharmaceuticals raised?
Syros Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Syros Pharmaceuticals last raise money?
Syros Pharmaceuticals's most recent round on record is a Series B, in Oct 2014.
What does Syros Pharmaceuticals do?
Syros Pharmaceuticals is a biotechnology company.
Where is Syros Pharmaceuticals headquartered?
Syros Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Syros Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Syros Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Syros Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.